For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies researching your condition/s 18

Based on the information you provided, you may be eligible for the following studies researching your condition/s.

  • Randomized, Open Label Study of MM-302 plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in Anthracycline Naive Patients with Locally Advanced/Metastatic HER2-Pos Breast Cancer Study purpose: see if MM-302 with trastuzumab can prevent cancer growth longer than other cancer drugs; find out if patients taking MM-302 combined with trastuzumab live longer, have fewer cancer symptoms, better quality of life, and fewer side effects than those receiving other cancer drugs This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Characteristics and Mechanisms of Cognitive Problems in Fibromyalgia Cognitive “fog" (slow and/or foggy thinking) is a very serious and common problem for people with different conditions such as fibromyalgia, depression, cancer, and multiple sclerosis. This study seeks to open a window onto the nature of cognitive fog in adults with these conditions. This study is researching all of the following topics: Breast cancer Depression Fibromyalgia Multiple sclerosis This study is looking for: male female both men and women Volunteers with specific conditions
    • 18 years to 60 years
  • An Open-Label, Phase 2 Study of Neratinib in Patients With Solid Tumors With Somatic Human Epidermal Growth Factor Receptor Mutations or EGFR gene amplification Study purpose: find out what effects, good and/or bad, experimental drug neratinib has in patients with a cancer that has a certain type of mutation: solid tumors that test positive for HER2 and HER3 mutations or EGFR (Epidermal Growth Factor Receptor) mutation or amplification in brain tumors. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Ovarian cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Improving Adherence to Oral Cancer Agents and Self-Care of Symptoms Using an IVR The purpose of the study is to: (1) determine if daily reminders will help patients take their anti-cancer pills as prescribed and; (2) test strategies to manage symptoms between doctor office visits. We are hoping to learn better ways to support patients who are prescribed oral anti-cancer pills. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Melanoma Pancreatic cancer Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors The purpose of this phase 1 research study is to evaluate the safety of an investigational drug, MEDI4736, a drug believed to boost a type of immune cell to assist in identifying and attacking cancer cells to determine the dose and schedule that is safe and tolerable in subjects with solid tumors. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Pancreatic cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Randomized Multicenter Pivotal Study of CDX-011 in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer. The study purpose is to see whether CDX-011 is effective in treating patients who have advanced Triple-Negative Breast Cancer (TNBC; i.e., tumors lacking expression of estrogen, progesterone and HER2 receptors) that contains GPNMB, and to examine the side effects associated with CDX-011 treatment. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Study of BMN 673 vs Physician's Choice in Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer with a maximum of 2 Prior Chemotherapy Regimens for Metastatic Disease The primary purpose of this study is to compare how well cancers respond to a PARP inhibitor (the investigational drug BMN 673) as compared to commonly used chemotherapy drugs. In addition, we will determine if the study drug BMN 673 is safe when given as a treatment for breast cancer. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1b, Open-label Study of Oral BGJ398 in Combination with Oral BYL719 in Adult Patients with Select Advanced Solid Tumors This clinical research study is to determine how much of experimental drugs BGJ398 and BYL719 can safely be given in combination to patients. Researchers would like to know how much of these two drugs can be given without causing serious side effects and also how these two drugs affect your body. This study is researching all of the following topics: Brain cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • UMCC 2013.098: Prospective pilot study evaluating the inter-relationships between sleep disturbance, fatigue, pain, and daytime activity in breast cancer patients starting aromatase inhibitor therapy Aromatase inhibitors are used to treat postmenopausal women with breast cancer. Although these drugs work very well, they can cause side effects. We are trying to understand the effect these medicines have on pain, sleep, fatigue, and activity, so that we can help women better tolerate the medicine. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • All ages welcome
Showing 1-10 of 18 studies
Show more studies

Studies researching other conditions 67

You may also be eligible for the following studies researching other conditions, either as a volunteer with condition/s or as a healthy volunteer.